RK
Rakesh Kumar Girdhar
About Rakesh Kumar Girdhar
Data last updated:
Rakesh Kumar Girdhar is a Whole-Time Director at Rajasthan Antibiotics Ltd (since 2008) and Director at Ral Nutralife Private Limited (since 2019). The companies operate in Pharma and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹384 Cr; the largest is Rajasthan Antibiotics Ltd at ₹383 Cr (FY 2025). Earlier, Rakesh Kumar Girdhar was a Director at Quad Lifesciences Private Limited (2012–2014) and Director at Arviv Lifesciences Private Limited (from 2015) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rajasthan Antibiotics Ltd U24231DL1986PLC023616 | Whole-Time Director | 01 Nov 2008 | 1986 | ₹383 Cr (FY 2025) | Active |
 Ral Nutralife Private Limited U51909UP2019PTC122131 | Director | 09 Oct 2019 | 2019 | ₹57.5 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Quad Lifesciences Private Limited U24232PB2012PTC038263 | Director | 19 Nov 2012 | 2012 | ₹124 Cr (FY 2025) | Active |
| Arviv Lifesciences Private Limited U52100DL2009PTC194061 | Director | 23 Jun 2015 | 2009 | ₹206 Cr (FY 2020) | Amalgamated |
| Revivaa Biotech Private Limited U52100DL2010PTC201633 | Director | 16 Apr 2010 | 2010 | ₹12 Lakh (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakesh Kumar Girdhar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aashish Pruthii | 01182469 | Rajasthan Antibiotics Ltd , Ral Nutralife Private Limited | Managing Director |
| Arvind Kharabanda | 00052270 | Rajasthan Antibiotics Ltd | Director |
| Bindu Acharya | 07223003 | Rajasthan Antibiotics Ltd | Director |
| Rajesh Kumar Jha | 08345857 | Rajasthan Antibiotics Ltd | Director |
| Sanjay Mittal | Rajasthan Antibiotics Ltd | Cfo | |
| Vijaysinh Vanvirsinh Chauhan | 07105066 | Rajasthan Antibiotics Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Kumar Girdhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Kumar Girdhar
Rakesh Kumar Girdhar currently holds 2 directorships: Rajasthan Antibiotics Ltd (Whole-Time Director, since 01 Nov 2008, revenue ₹383 Cr (FY 2025)); Ral Nutralife Private Limited (Director, since 09 Oct 2019, revenue ₹57.5 Lakh (FY 2023)).
Rakesh Kumar Girdhar was first appointed on 01 Nov 2008 as Whole-Time Director at Rajasthan Antibiotics Ltd. The most recent appointment on record is 09 Oct 2019 at Ral Nutralife Private Limited.
The 2 current companies of Rakesh Kumar Girdhar that report revenue have a combined latest revenue of ₹384 Cr: Rajasthan Antibiotics Ltd ₹383 Cr (FY 2025); Ral Nutralife Private Limited ₹57.5 Lakh (FY 2023).
Rakesh Kumar Girdhar held 3 earlier board appointments: Quad Lifesciences Private Limited (Director, 19 Nov 2012 to 06 Feb 2014); Arviv Lifesciences Private Limited (Director, from 23 Jun 2015); Revivaa Biotech Private Limited (Director, from 16 Apr 2010).
The current boards of Rakesh Kumar Girdhar's companies include Aashish Pruthii (Rajasthan Antibiotics Ltd), Arvind Kharabanda (Rajasthan Antibiotics Ltd), Bindu Acharya (Rajasthan Antibiotics Ltd), Rajesh Kumar Jha (Rajasthan Antibiotics Ltd), Sanjay Mittal (Rajasthan Antibiotics Ltd), Vijaysinh Vanvirsinh Chauhan (Rajasthan Antibiotics Ltd).